Event Date/Time: Nov 15, 2010
End Date/Time: Nov 16, 2010
This years' conference on Clinical Trials in CNS, is taking place on the 15th and 16th November 2010 in London, and will bring together leading industry experts to explore the current and future opportunities within CNS drug development.
Representing the second largest therapeutic segment of the pharmaceutical market it is also one of the fastest growing. This year SMi Group's conference aims to cover clinical drug discovery activities, new therapeutic targets, as well as effective CNS drug development strategies and problems encountered in clinical trials, with in-depth discussions and case study presentations from the key industry players.
Donâ€™t forget to register for our half day post-conference workshop;
Overcoming the Low Success Rate of New CNS Drugs
Taking place on the 17th July 2010 at the Marriott Hotel, Regents Park, in London. Hosted by Jill Rasmussen, Vice President and Director at Psi-Napse, and co-hosted by Alan Palmer, Chief Scientific Officer at MS Therapeutics
This interactive workshop will explore ways to improve the efficiency and effectiveness of CNS medicines research, and provide you with knowledge of successful strategies for dealing with the problems associated with CNS clinical trials.